*"Do or do not. There is no try."* — Yoda, Star Wars Every time I hear this I want to argue with a 900-year-old puppet. Trying counts. Trying is brave. But here's the scene: Luke says he'll try, then only half-lifts the ship before giving up. Yoda's not knocking effort... he's calling out the belief baked into "I'll try": the quiet expectation it won't fully work, before you've even started. 👇 Where are you doubting yourself into a half-attempt this week?

Watcha doing for yourself this weekend? Share what will spark some joy! Golly gosh I'll be by the lake with fam!

Something I want to be really clear about, because I see this get missed a lot. There's nothing wrong with considering an omega-3 supplement. But if you're taking one while your day-to-day plate is still heavy in red meat, eggs, and butter... you're fighting an uphill battle. This isn't about one nutrient. It's a ratio, and it works together. ​ Here's the nuance that matters, because I don't want you fearing the wrong thing: this was never really a "seed oils are bad" story. The specific fat the research flags (arachidonic acid) comes mainly from animal fat... red meat, egg yolks, dairy... not from olive oil, nuts, or seeds. So the fix isn't avoidance, it's shifting the balance of what's already on your plate. ​ Which is basically just... the actual Mediterranean diet, the real published version, not the internet's version of it: ​ Olive oil, every meal, as your primary fat. Fish or seafood, 2+ times a week... that's your omega-3. Nuts and seeds, most days. Eggs, 2 to 4 a week, not unlimited but not restricted either. Poultry, about twice a week. Red meat, under twice a week, lean cuts. Processed meat, once a week or less. ​ One honest caveat: the PMOS-specific research on this ratio is observational... based on what people already eat, not supplement trials. What we DO have a real trial for is the broader inflammation link: a Mediterranean-diet study (general population, not PMOS-specific) found this exact shift lowered CRP, a real inflammation marker, compared to a low-fat diet. Different population, same mechanism... honest, not proof, but a strong signal. ​ 📎 The fatty acid research: https://pubmed.ncbi.nlm.nih.gov/42459808/ 📎 The Mediterranean diet trial: https://pubmed.ncbi.nlm.nih.gov/16818923/ ​ Have you ever taken a supplement without changing what was already on your plate? What happened... or didn't?

I read a study this week that made me pause. 587 women with PMOS. 84.5% of them had pathological scores on a validated body image scale. Not "some." Not "a subset." Eighty-four point five percent. ​ And here's the part that matters clinically: when researchers ran the numbers, poor body image wasn't just showing up alongside anxiety and depression scores in this group... it was independently linked to both, even after accounting for other factors. ​ Body image isn't a footnote to PMOS mental health. In this data, it's one of the main drivers. ​ I want to be careful here, because "just lose weight" is not what this means. What it means is: if a provider is only screening for depression or anxiety with a generic checklist, and never asks how someone feels about their body, they're missing one of the biggest levers in the room. ​ 📎 The study: https://pubmed.ncbi.nlm.nih.gov/39945793/ ​ If body image has been part of your PMOS experience, I'd love to hear how... good, bad, or complicated.

This is the kind of study I get excited about, because it's not theoretical. It's real numbers. ​ 96 women with PMOS and a BMI over 25 went through six months of semaglutide treatment. Before treatment, 83% had irregular or absent ovulation. After six months... average weight dropped about 11%, and ovulatory cycles returned in over half of previously anovulatory women. In the overweight (not obese) group specifically, almost 95% saw their cycles normalize. ​ I want to be precise about what this does and doesn't say. This isn't "GLP-1s cure PMOS." It's evidence that for a specific group, treating the metabolic piece first (weight, insulin resistance) can be what unlocks the cycle piece, before jumping straight to fertility-specific treatments. The authors' own conclusion: consider GLP-1 agonists before treatments aimed only at inducing ovulation, for the right patients. ​ This is exactly the "sequence matters" conversation I have all the time. Not every path to regular cycles runs through a fertility drug first. Sometimes it runs through the metabolic piece. ​ 📎 The study: https://pubmed.ncbi.nlm.nih.gov/42452625/ ​ Has anyone here had a provider talk to you about GLP-1s as part of your PMOS care... not just for weight, but for cycles? I'd love to know how that conversation went.